Skip to content

Bone Scintigraphy and Unicompartimental Knee Arthroplasty

Interest of Bone Scintigraphy in Pre-operative Assessment of Knee Osteoarthritis in Patients Undergoing Unicompartmental Knee Arthroplasty

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03145090
Acronym
PUC-INTEVO
Enrollment
100
Registered
2017-05-09
Start date
2017-03-16
Completion date
2019-10-11
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Scintigraphy and Knee Arthroplasty

Keywords

bone scintigraphy, knee arthroplasty, spect-ct, quantification

Brief summary

Study the potential interest of bone scintigraphy for patients undergoing unicompartmental knee arthroplasty

Detailed description

Knee osteoarthritis is a very common disease with significant functional consequences. Surgical treatment is the ultimate treatment with the possibility of replacing only one compartment or the 3 joint compartments. Consequently, the pre-surgical imaging is essential to ensure that the 3 compartments are not compromised when a uni-compartmental prosthesis (PUC) is considered. The scintigraphy because of its good diagnostic performance seems to be interesting in this indication for the preoperative assessment of knee uni-compartmental prostheses to ensure the absence of degenerative lesion of the unoperated compartment. This study will evaluate the impact of bone scintigraphy on surgery and the potential correlation between scintigraphic and clinical data; study the pronostic impact of bone scintigraphy

Interventions

None listed

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* patient over 18 years old / uni or bilateral unicompartmental knee prothesis/ non opposition

Exclusion criteria

* Under 18 years old/ contraindications for bone scintigraphy/ refusal to participate

Design outcomes

Primary

MeasureTime frameDescription
modification in surgical strategy according to bone scintigraphy results18 monthspourcentage of therapeutic modification according to bone scintigraphy results

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026